This is a StreetInsider.com Premium Only Page

(TERN) – StreetInsider.com Reports

Mar 27, 2024 08:46 AM Terns Pharmaceuticals (TERN) PT Lowered to $18 at UBS

Mar 18, 2024 02:38 AM Terns Pharmaceuticals (TERN) PT Lowered to $15 at JMP Securities

Mar 15, 2024 06:41 AM Terns Pharmaceuticals (TERN) PT Raised to $19 at BMO Capital

Feb 7, 2024 08:05 AM Terns Pharmaceuticals (TERN) Appoints Amy Burroughs as CEO

Jan 18, 2024 07:48 AM Terns Pharmaceuticals (TERN) PT Raised to $22 at Jefferies

Jan 10, 2024 06:44 AM Terns Pharmaceuticals (TERN) PT Lowered to $5.50 at H.C. Wainwright

Dec 7, 2023 08:49 AM Will this be the next obesity stock to be acquired?

Nov 27, 2023 04:05 PM Terns Pharmaceuticals (TERN) Announces Passing of Ex-CEO Senthil Sundaram

Nov 27, 2023 06:46 AM Terns Pharmaceuticals (TERN) PT Lowered to $10 at Mizuho Securities

Nov 13, 2023 08:08 AM Terns Pharmaceuticals (TERN) Presents Late-Breaking Data from Phase 2a DUET Trial of THR-β Agonist TERN-501 in NASH

Oct 16, 2023 08:05 AM Terns Pharmaceuticals (TERN) Announces Global Phase 1 Clinical Trial Design of TERN-701

Aug 10, 2023 06:44 AM Terns Pharmaceuticals (TERN) PT Lowered to $8 at H.C. Wainwright

Aug 9, 2023 07:15 AM Terns Pharmaceuticals (TERN) PT Raised to $11 at JPMorgan

Aug 9, 2023 06:41 AM Terns Pharmaceuticals (TERN) PT Raised to $17 at Mizuho Securities

Aug 8, 2023 06:03 PM Terns Pharmaceuticals, Inc. (TERN) Tops Q2 EPS by 8c

Aug 8, 2023 05:58 PM Terns Pharmaceuticals, Inc. (TERN) Tops Q2 EPS by 8c

Aug 8, 2023 04:05 PM Terns Pharmaceuticals Inc. (TERN) Reports TERN-501 Met Primary Endpoint and All Secondary Endpoints in Phase 2a DUET Trial

Aug 3, 2023 05:05 PM Terns Pharmaceuticals (TERN) Announces CEO Transition

Jun 26, 2023 04:07 PM Terns Pharmaceuticals Inc. (TERN) Highlights New Preclinical Data for TERN-601 Program in Obesity at the ADA’s 83rd Annual Scientific Session and Upcoming Events

Jun 22, 2023 04:12 AM Mizuho Securities Starts Terns Pharmaceuticals (TERN) at Buy

Jun 7, 2023 03:27 AM Jefferies Starts Terns Pharmaceuticals (TERN) at Buy

May 30, 2023 04:37 PM Roth/MKM Starts Terns Pharmaceuticals (TERN) at Buy, 'To the Liver and Beyond'

May 25, 2023 05:05 PM Terns Pharmaceuticals (TERN) Announces Publication of TERN-701 Trial-in-Progress Abstract

May 16, 2023 07:32 AM Terns Pharmaceuticals (TERN) PT Raised to $10 at JPMorgan

May 8, 2023 05:04 AM BMO Capital Starts Terns Pharmaceuticals (TERN) at Outperform

May 5, 2023 06:13 AM Terns Pharmaceuticals (TERN) PT Raised to $15 at Goldman Sachs

Mar 29, 2023 07:18 AM Terns Pharmaceuticals (TERN) PT Raised to $9 at JPMorgan

Mar 29, 2023 06:35 AM Terns Pharmaceuticals (TERN) PT Raised to $11 at H.C. Wainwright

Mar 29, 2023 06:13 AM Terns Pharmaceuticals (TERN) PT Raised to $11 at H.C. Wainwright

Mar 27, 2023 04:06 PM Terns Pharmaceuticals (TERN) Reports Q4, Provides Corporate Update

Mar 27, 2023 08:05 AM Terns Pharmaceuticals Inc. (TERN) Appoints Emil Kuriakose as Chief Medical Officer of Terns Oncology

Feb 14, 2023 02:21 AM JMP Securities Starts Terns Pharmaceuticals (TERN) at Market Outperform

Feb 7, 2023 07:48 AM UBS Starts Terns Pharmaceuticals (TERN) at Buy

Feb 1, 2023 04:28 PM Terns Pharmaceuticals Inc. (TERN) Files $400M Mixed Shelf

Dec 29, 2022 06:13 AM Terns Pharmaceuticals (TERN) PT Raised to $7 at H.C. Wainwright

Dec 21, 2022 05:57 AM Terns Pharmaceuticals (TERN) Prices 10.35M Share Offering at $7.25/sh

Dec 19, 2022 05:38 PM After-hours movers: Lucid gains on liquidity boost, Entrada Therapeutics sinks on FDA hold

Dec 19, 2022 04:31 PM Terns Pharmaceuticals Inc. (TERN) Launches $75M Public Offering

Dec 19, 2022 10:47 AM Terns (TERN) PT Raised to $14 at Goldman: 'We expect TERN shares to trade higher today following MDGL's report'

Nov 4, 2022 08:06 AM Terns Pharmaceuticals (TERN) Highlights Results from Phase 1 Clinical Trial of TERN-501 at AASLD

Sep 27, 2022 05:45 PM After-Hours Movers: Frontier Gains on Index Move, Mind Medicine Falls on Offering

Sep 27, 2022 04:19 PM Terns Pharmaceuticals (TERN) PT More Than Doubled to $9 at Goldman Sachs

Sep 12, 2022 06:08 AM UPDATE: H.C. Wainwright Starts Terns Pharmaceuticals (TERN) at Neutral

Aug 12, 2022 08:00 AM Terns Pharmaceuticals Inc. (TERN) Announces $65M Stock and Warrant Offering at $2.42/sh

Jul 27, 2022 04:09 PM Terns Pharmaceuticals Inc. (TERN) Appoints Radhika Tripuraneni to its Board

Jun 1, 2022 04:06 PM Terns Pharmaceuticals Inc. (TERN) Appoints Kerry Russell as Chief Medical Officer

Mar 23, 2022 06:04 AM UPDATE: JPMorgan Downgrades Terns Pharmaceuticals (TERN) to Neutral

Mar 22, 2022 12:48 PM Cowen Reiterates Outperform Rating on Terns Pharmaceuticals (TERN), Believes VAP-1 is Not Well Understood and Could be Underappreciated

Mar 21, 2022 04:05 PM Terns Pharmaceuticals Inc. (TERN) Reports Top-line Results from Phase 1 AVIATION Trial of VAP-1 Inhibitor TERN-201

Mar 8, 2022 04:36 PM Terns Pharmaceuticals Inc. (TERN) Files $250M Mixed Shelf